title: Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
authors.affiliation: Division of Cardiology, St Michael's Hospital, University of Toronto, 30 Bond St., 6-050 Queen Wing, Toronto, ON, Canada. dorianp@smh.toronto.on.ca
authors.forename: Hugo
authors.initials: H
authors.lastname: Van Herendael
authors.forename: Arnold
authors.initials: A
authors.lastname: Pinter
authors.forename: Kamran
authors.initials: K
authors.lastname: Ahmad
authors.forename: Victoria
authors.initials: V
authors.lastname: Korley
authors.forename: Iqwal
authors.initials: I
authors.lastname: Mangat
authors.forename: Paul
authors.initials: P
authors.lastname: Dorian
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D006801:Humans; D018579:Patient Selection; D017180:Tachycardia, Ventricular / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents